Karyopharm appoints zhen su, md, mba to its board of directors

Newton, mass. , sept. 1, 2023 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of zhen su, md, mba, to its board of directors, effective august 31, 2023.
KPTI Ratings Summary
KPTI Quant Ranking